Status:
COMPLETED
Predictive Urodynamic Parameters for The Treatment Efficacy of Onabotulinum A Toxin in Neurogenic Lower Urinary Tract Dysfunction
Lead Sponsor:
University of Gaziantep
Conditions:
Neurogenic Bladder Disorder
Eligibility:
All Genders
18+ years
Brief Summary
Purpose: To evaluate urodynamic parameters predicting the treatment efficacy of onabotulinumtoxin A (onaBoNT-A) in patients with neurogenic lower urinary tract dysfunction (NLUTD). Methods: Patients ...
Eligibility Criteria
Inclusion
- Patients with Neurogenic Lower Urinary Tract Disorder
- Aged \>18 years
- Patients who did not respond adequatel to antimuscarinics or could not tolerate their side effects
- Antimuscarinic treatment failure with at least two different antimuscarinic agents for a minimum of 3 months.
Exclusion
- Patients with Lower Urinary Tract Disorder due to functional or non-neurogenic etiologies
- Patients who received onaBoNT-A doses either other than 200 IU or its multiple doses
- In the 12-month period designated for patient follow-up, patients who did not attend their check-ups
Key Trial Info
Start Date :
September 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2024
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT06485453
Start Date
September 1 2013
End Date
June 1 2024
Last Update
July 3 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.